Recent Finacing
Recent Raise
Emtora Biosciences is a clinical-stage biopharmaceutical company developing eRapa, an encapsulated rapamycin formulation, pursuing a 505(b)(2) regulatory pathway and conducting Phase 2–3 trials for FAP and bladder cancer.
